Estrella Immunopharma
ESLA
ESLA
13 hedge funds and large institutions have $879K invested in Estrella Immunopharma in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$131K | |
| 2 | +$10.3K | |
| 3 | +$9.96K | |
| 4 |
SS
SBI Securities
Tokyo,
Japan
|
+$1 |
Top Sellers
| 1 | -$21.5K | |
| 2 | -$14K | |
| 3 | -$7.03K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.77K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$555 |